Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (151-160 of 252) with videos related to

Pageof 26
Sort By:
Antiviral Therapy|March 31, 2011
Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosisAlejandro Arenas-Pinto, Alison Grant, Krishnan Bhaskaran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort StudyHeiner C Bucher, Werner Richter, Tracy R Glass, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2010
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort studyBarbara Hasse, Bruno Ledergerber, Bernard Hirschel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort StudyTracy R Glass, Sabina De Geest, Rainer Weber, et al.
AIDS (London, England)|November 2, 2005
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovirUrs Karrer, Bruno Ledergerber, Hansjakob Furrer, et al.
Antiviral Therapy|February 20, 2010
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapyHeiner C Bucher, Martin Rickenbach, Jim Young, et al.
Science Advances|September 29, 2021
Novel synthetic pathway for the production of phosgenePatrick Voßnacker, Alisa Wüst, Thomas Keilhack, et al.
Blood|June 10, 2004
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set pointAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Open Forum Infectious Diseases|November 2, 2020
Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT AngiographyPhilip E Tarr, Bruno Ledergerber, Alexandra Calmy, et al.
Antiviral Therapy|April 28, 2006
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort studyAnnelies S Zinkernagel, Viktor von Wyl, Bruno Ledergerber, et al.
Pageof 26

Showing results (151-160 of 252) with videos related to

Sort By:
Pageof 26
Antiviral Therapy|March 31, 2011
Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosisAlejandro Arenas-Pinto, Alison Grant, Krishnan Bhaskaran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort StudyHeiner C Bucher, Werner Richter, Tracy R Glass, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2010
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort studyBarbara Hasse, Bruno Ledergerber, Bernard Hirschel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort StudyTracy R Glass, Sabina De Geest, Rainer Weber, et al.
AIDS (London, England)|November 2, 2005
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovirUrs Karrer, Bruno Ledergerber, Hansjakob Furrer, et al.
Antiviral Therapy|February 20, 2010
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapyHeiner C Bucher, Martin Rickenbach, Jim Young, et al.
Science Advances|September 29, 2021
Novel synthetic pathway for the production of phosgenePatrick Voßnacker, Alisa Wüst, Thomas Keilhack, et al.
Blood|June 10, 2004
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set pointAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Open Forum Infectious Diseases|November 2, 2020
Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT AngiographyPhilip E Tarr, Bruno Ledergerber, Alexandra Calmy, et al.
Antiviral Therapy|April 28, 2006
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort studyAnnelies S Zinkernagel, Viktor von Wyl, Bruno Ledergerber, et al.
Pageof 26